Primary Cells Market Size, Share, Growth Drivers, Emerging Trends, Key Segments, Leading Players, and Forecast - 2029

The primary cells industry is poised for significant advancements and growth in the near future. As researchers and pharmaceutical companies continue to recognize the limitations of cell lines, primary cells are gaining prominence as a more physiologically relevant and accurate model for studying human biology and disease.
Primary Cells Market [https://www.marketsandmarkets.com/Market-Reports/primary-cells-market-32854960.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $1.7 billion in 2023 and is poised to reach $2.8 billion by 2028, growing at a CAGR of 10.5% from 2023 to 2028 according to a new report by MarketsandMarkets Trademark . The growth of this market can be attributed to factors such as the is government investments for cell-based research, rising growth in pharmaceutical & biotechnology industries, increasing cancer research, increasing demand for monoclonal antibodies, increasing demand for personalized medicine, and growing advantages of primary human cells over cell lines.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

human primary cells segment accounted for the dominant share of the primary cells market, by origin."

On the basis of origin, the primary cells market is categorized into animal and human primary cells. In 2022, the human primary cells segment accounted for the largest share of the primary cells market. Factors responsible for the growth of the segment include the demand for accurate disease models, increasing application in studying cancer stem cells and drug-drug interactions in cancerous cells and circulating tumor cells, increasing the burden of chronic diseases, safety testing requirements, and ethical considerations.

"Hematopoietic cells segment accounted for the largest share in the primary cells market, by type in 2022."

On the basis of type, the primary cells market is divided into hematopoietic cells, dermatocytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and other primary cells. Hematopoietic cell transplants are frequently used to develop novel cancer therapies to treat blood cancers and other disorders of the immune system. Hematopoietic cells are also used to study the biochemical pathways of tumor cells and the efficacy of different drugs. This wide range of applications will contribute to the largest share of the hematopoietic cells in the primary cells market in 2022.

"In 2022, the pharmaceutical & biotechnology companies, and CROs segment accounted for the largest share of the global primary cells market, by end user."

On the basis of end users, the primary cells market is segmented into pharmaceutical & biotechnology companies, and CROs, academic & research institutes, and other end users. In 2022, pharmaceutical & biotechnology companies and CROs accounted for the largest share of the primary cells market, mainly due to the high adoption of primary cells among pharmaceutical & biotechnology companies and CROs for cell-based experiments and cancer research.

"In 2022, North America is the largest regional market for primary cells."

The global primary cells market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2022, North America accounted for the largest share of the primary cells market. The increasing number of players launching new human primary cells for research, expansion in the pharmaceutical and biotechnology industries, rising incidences of cancer and various other chronic and infectious diseases, and the growing focus on R&D in the region are the major factors driving the growth of the North American market. As life science research studies have significant use of primary cells, the growing focus on R&D in this field is expected to drive market growth in North America during the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Primary Cells Market Dynamics:

Drivers:

* Increasing cancer research
* Advantages of primary human cells over cell lines
* Increasing demand for monoclonal antibodies
* Rapid growth in biotechnology and biopharmaceutical industries
* Growing focus on personalized medicine
* Government investments for cell-based research

Restraints:

* Concerns regarding primary cell culture contamination
* Ethical concerns regarding research in cell biology

Opportunities:

* Advancing biomedical research using primary cells in 3D cultures

Challenges:

* Sourcing and availability of primary cells

Key Market Players:

Key players in the primary cells market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza Group (Switzerland), Cell Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US), ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated (US), AllCells (US), American Type Culture Collection (US), Axol Bioscience Ltd. (UK), iXCells Biotechnologies (US), Neuromics (US), StemExpress (US), BioIVT (US), ScienCell Research Laboratories, Inc. (US), ProMab Biotechnologies, Inc. (US), Creative Bioarray (US), BPS Bioscience, Inc. (US), Epithelix (Switzerland), ReachBio LLC (US), AcceGen (US), AMSBIO (UK), and Kosheeka (India).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32854960 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32854960&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Primary Cells Market Advantages:

* Physiological Relevance: Primary cells, derived directly from human or animal tissues, closely resemble the characteristics and behavior of cells in their native environment. This physiological relevance allows researchers to study cellular responses, interactions, and functions more accurately, leading to a better understanding of human biology and disease mechanisms. Compared to cell lines, primary cells provide a more representative model for investigating drug efficacy, toxicity, and personalized medicine approaches.
* Genetic Diversity: Primary cells exhibit natural genetic variations, reflecting the diversity of individuals and populations. This diversity enables researchers to explore the impact of genetic factors on disease development, drug response, and treatment outcomes. By utilizing primary cells from different donors, scientists can investigate inter-individual variability, identify biomarkers, and develop targeted therapies for specific patient populations.
* Complex Cellular Interactions: Primary cells maintain the complex interactions found within tissues, allowing researchers to study cell-to-cell communication, signaling pathways, and microenvironmental influences accurately. This capability is particularly crucial for investigating diseases that involve intricate cellular crosstalk, such as cancer, immune disorders, and neurodegenerative conditions. Primary cells facilitate the evaluation of complex disease mechanisms and the development of more effective therapeutic interventions.
* Translational Research Potential: Primary cells offer translational research opportunities by bridging the gap between in vitro experiments and clinical applications. Their ability to closely resemble human physiology enhances the predictability of preclinical studies, allowing for more accurate assessment of drug efficacy, safety, and potential side effects. Primary cells also serve as valuable tools for evaluating patient-specific responses to treatments, enabling the development of personalized medicine approaches.
* Emerging Technologies Integration: The primary cells market is witnessing integration with emerging technologies, such as 3D bioprinting, organ-on-a-chip systems, and high-throughput screening platforms. These advancements enable the creation of more complex and functional in vitro models that closely mimic human tissues and organs. The combination of primary cells with these technologies enhances their utility in drug discovery, regenerative medicine, and toxicology studies.

Overall, the primary cells market's advantages, including physiological relevance, genetic diversity, complex cellular interactions, translational research potential, and integration with emerging technologies, make them an invaluable resource for advancing biomedical research, drug development, and personalized healthcare approaches.

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=primary-cells-market-size-share-growth-drivers-emerging-trends-key-segments-leading-players-and-forecast-2029]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/primary-cells-market-32854960.html



This release was published on openPR.